These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 1175883

  • 1. Serum lysozyme in Crohn's disease. A useful index of disease activity.
    Falchuk KR, Perrotto JL, Isselbacher KJ.
    Gastroenterology; 1975 Oct; 69(4):893-6. PubMed ID: 1175883
    [Abstract] [Full Text] [Related]

  • 2. Serum lysozyme in Crohn's disease and ulcerative colitis.
    Falchuk KR, Perrotto JL, Isselbacher KJ.
    N Engl J Med; 1975 Feb 20; 292(8):395-7. PubMed ID: 1110725
    [Abstract] [Full Text] [Related]

  • 3. The diagnostic value of serum lysozyme activity in inflammatory bowel disease.
    Ayulo JA, Chen CC, Pelot D, Berk JE.
    Am J Gastroenterol; 1977 Jul 20; 68(1):71-6. PubMed ID: 910787
    [Abstract] [Full Text] [Related]

  • 4. Serum lysozyme in Crohn's disease and ulcerative colitis.
    Helman CA, Novis BH, Bank S, Wormold L, Jacobs P.
    S Afr Med J; 1977 Dec 17; 52(26):1042-4. PubMed ID: 609977
    [Abstract] [Full Text] [Related]

  • 5. Serum lysozyme in Crohn's disease and ulcerative colitis.
    Hylander E, Hansen NE, Karle H, Janrum S.
    Scand J Gastroenterol; 1976 Dec 17; 11(2):213-7. PubMed ID: 1265442
    [Abstract] [Full Text] [Related]

  • 6. Plasma lysozyme levels and decay of neutrophilic granulocytes in patients with Crohn's disease.
    van de Merwe JP, Lindemans J, Mol GJ.
    Hepatogastroenterology; 1980 Apr 17; 27(2):130-4. PubMed ID: 7216126
    [Abstract] [Full Text] [Related]

  • 7. Altered subjective appetite parameters in Crohn's disease patients.
    Bannerman E, Davidson I, Conway C, Culley D, Aldhous MC, Ghosh S.
    Clin Nutr; 2001 Oct 17; 20(5):399-405. PubMed ID: 11534934
    [Abstract] [Full Text] [Related]

  • 8. Serum lysozyme levels in inflammatory bowel disease.
    Manier JW, Roberts RC, Zais DP.
    Am J Gastroenterol; 1977 Mar 17; 67(3):245-8. PubMed ID: 868843
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease.
    Gao Q, Hogezand RA, Lamers CB, Verspaget HW.
    Aliment Pharmacol Ther; 2004 Sep 01; 20(5):585-92. PubMed ID: 15339330
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Serum lysozyme in ulcerative colitis and Crohn's disease].
    Belaiche J, Zittoun J, Vesin P, Bernier JJ, Cattan D.
    Arch Fr Mal App Dig; 1976 Jun 01; 65(4):261-4. PubMed ID: 1015972
    [No Abstract] [Full Text] [Related]

  • 16. Serum lysozyme levels in Crohn's disease and ulcerative colitis.
    Peeters TL, Vantrappen G, Geboes K.
    Gut; 1976 Apr 01; 17(4):300-5. PubMed ID: 773792
    [Abstract] [Full Text] [Related]

  • 17. Letter: Serum lysozyme levels in Crohn's disease and ulcerative colitis.
    Hylander E, Hansen NE, Karle H, Jarnum S.
    N Engl J Med; 1976 Jan 08; 294(2):111. PubMed ID: 1244493
    [No Abstract] [Full Text] [Related]

  • 18. Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease.
    Jones J, Loftus EV, Panaccione R, Chen LS, Peterson S, McConnell J, Baudhuin L, Hanson K, Feagan BG, Harmsen SW, Zinsmeister AR, Helou E, Sandborn WJ.
    Clin Gastroenterol Hepatol; 2008 Nov 08; 6(11):1218-24. PubMed ID: 18799360
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.